Sorry about that I am an RRT with many years in Home care and Sleep.
I will try to find you studies on
CPAP induced Centrals but I am finding that kind of hard so here is a few references on central apnea. I will ask around for hard evidence on the pressure stuff. I am thinking though since there are probably 15000 or more
Auto CPAP out there . Most of them set to go to a max of 18-20 cmH20 and the manufactures have not be sued out of business yet . That pressure induced Central apnea below a pressure of 18-20 is very Rare.
http://www.e-breathing.com/
Baro receptors or
Stretch receptors in the lungs also act to modify respiration. The Hering-Breuer reflex is stimulated when the lungs are stretched. Stretch receptors in the bronchi and bronchioles transmit inhibitory signals to the inspiratory center. This is a protective measure to prevent the lungs from being overinflated. Stretch receptors also send information about lung deflation to the brainstem. Respiration is affected by emotional cues and input from the position sensors (proprioceptors) in joints and muscle.
Chemoreceptors in the carotid and aortic bodies provide additional information to the integrating centers in the brainstem regarding peripheral levels of oxygen and carbon dioxide. Such regulation maintains alveolar PCO2 at normal levels, holds H+ in check and elevates PO2 as necessary. Alveolar PO2 is higher than needed to saturate hemoglobin. Therefore, changes in alveolar PCO2 have a greater effect on respiration. The carotid bodies are located at the branch point of the carotid arteries and the aortic bodies are found within the aortic arch. Carotid chemosensors sense a decrease in arterial PO2, especially below 50 mmHg, and increased PCO2 and H+. The aortic bodies sense increased PCO2 and H+. Chemoreceptors in the brain monitor the concentration of H+ in cerebrospinal fluid which closely parallels the PCO2 in blood.
http://www.highwire.org/cgi/searchresul ... disp_type=
Journal of Applied Physiology
Vol. 82, No. 3, pp. 918-926, March 1997
CONTROL OF BREATHING, CIRCULATION, AND TEMPERATURE
Effects of inhaled CO2 and added dead space on idiopathic central sleep apnea
Ailiang Xie, Fiona Rankin, Ruth Rutherford, and T. Douglas Bradley
Sleep Research Laboratory, Queen Elizabeth Hospital, and Department of Medicine, Toronto Hospital, University of Toronto, Toronto, Ontario, Canada M5G 2C4
Received 21 February 1996; accepted in final form 3 November 1996.
Xie, Ailiang, Fiona Rankin, Ruth Rutherford, and T. Douglas Bradley. Effects of inhaled CO2 and added dead space on idiopathic central sleep apnea. J. Appl. Physiol. 82(3): 918-926, 1997.We hypothesized that reductions in arterial PCO2 (PaCO2) below the apnea threshold play a key role in the pathogenesis of idiopathic central sleep apnea syndrome (ICSAS). If so, we reasoned that raising PaCO2 would abolish apneas in these patients. Accordingly, patients with ICSAS were studied overnight on four occasions during which the fraction of end-tidal CO2 and transcutaneous PCO2 were measured: during room air breathing (N1), alternating room air and CO2 breathing (N2), CO2 breathing all night (N3), and addition of dead space via a face mask all night (N4). Central apneas were invariably preceded by reductions in fraction of end-tidal CO2. Both administration of a CO2-enriched gas mixture and addition of dead space induced 1- to 3-Torr increases in transcutaneous PCO2, which virtually eliminated apneas and hypopneas; they decreased from 43.7 ± 7.3 apneas and hypopneas/h on N1 to 5.8 ± 0.9 apneas and hypopneas/h during N3 (P < 0.005), from 43.8 ± 6.9 apneas and hypopneas/h during room air breathing to 5.9 ± 2.5 apneas and hypopneas/h of sleep during CO2 inhalation during N2 (P < 0.01), and to 11.6% of the room air level while the patients were breathing through added dead space during N4 (P < 0.005). Because raising PaCO2 through two different means virtually eliminated central sleep apneas, we conclude that central apneas during sleep in ICSA are due to reductions in PaCO2 below the apnea threshold.
Oh and I can find you studies where they are treating Certain Central apnea with
CPAP pressure and 02
This is the most common cause of Central apnea which is heart failure which causes Cheyne-Stokes breathing. Very tricky to titrate well.
hypocapnia = not enough Co2 so you hold your breath to build up enough in your system causeing a Central Apnea .
Am. J. Respir. Crit. Care Med., Vol 150, No. 6, Dec 1994, 1598-1604.
Effect of continuous positive airway pressure on central sleep apnea and nocturnal PCO2 in heart failure
MT Naughton, DC Benard, R Rutherford and TD Bradley
Sleep Research Laboratory, Queen Elizabeth Hospital, Toronto, Ontario, Canada.
We have previously shown that hypocapnia triggers Cheyne-Stokes respiration with central sleep apnea (CSR-CSA) in patients with congestive heart failure (CHF). Nasal continuous positive airway pressure (NCPAP) may attenuate CSR-CSA in patients with CHF and CSR-
CSA. Accordingly, we hypothesized that attenuation of CSR-CSA by NCPAP would be related to an increase in PCO2. Therefore, we examined the effect of NCPAP on the frequency of apneas and hypopneas, transcutaneous PCO2 (PtcCO2), and minute volume of ventilation (VI) in 12 consecutive patients with CHF and CSR-CSA during stage 2 sleep. A control group of six patients, who did not receive NCPAP, was also studied. In the control group, there were no changes from baseline to 1 mo in the frequency of central apneas and hypopneas, mean PtcCO2, mean VI, or mean SaO2 during stage 2 sleep. In contrast, from baseline to 1 mo the NCPAP group experienced a decrease in the frequency of apneas and hypopneas (58.7 +/- 5.2 to 23.2 +/- 6.0/h of sleep, p < 0.001), an increase in mean PtcCO2 (34.6 +/- 1.4 to 40.8 +/- 1.1 mm Hg, p < 0.001), a reduction in mean VI (8.1 +/- 1.0 to 5.2 +/- 0.5 L/min, p < 0.01) and an increase in mean SaO2 (91.6 +/- 1.1 to 95.0 +/- 0.5%, p < 0.025) during stage 2 sleep while on 10.2 +/- 0.5 cm H2O nasal
CPAP. We conclude that likely mechanisms through which NCPAP reduces CSR-CSA are by increasing SaO2 and raising PaCO2 during sleep toward or above the apneic threshold.